Advocacy Activities: Engage in advocacy efforts. Integrate former study participants from FDA clinical trials studying psychedelic compounds. Information Sharing: Collaborate with academic researchers. Identify FDA clinical trials for potential study participants. Public Education: Educate the public and policymakers about scientific research in FDA clinical trials related to psychedelic compounds.